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Abstract
Four patients w ith  b ilateral ocular surface squam ous neoplasia attended to at Sekuru K aguvi H ospital Eye 
U n it are being presented to  alert practitioners that O SSN  is potentially  a b ilateral d isease and its prevalence is 
likely to increase as the life expectancy o f  H IV  infected  patients is being positively  affected by antiretroviral 
therapy. R eports on ocular diseases should  be clear on  laterality  to  avoid  confusion betw een num ber o f  
patients affected and num ber o f  eyes involved since the tw o cannot be used interchangeably.
Introduction
Ocular surface squamous neoplasias (OSSN) range 
from dysplasias, carcinoma in-situ to invasive 
squamous cell carcinoma o f the conjunctiva.1'2 The 
geographical distribution o f OSSN world over has not 
been spared by the HIV / AIDS pandemic, with 
countries like Zimbabwe reporting its first cases from 
1990 ten years after the pandemic and Uganda, Malawi 
and Tanzania noticing dramatic increases in OSSN 
prevalence rates respectively.3’5 The annual prevalence 
rate o f the disease in Zimbabwe has been escalating 
with the National Cancer Registry rating it to be the 
fourth most frequently registered malignancy in the 
country.6
The disease is associated with high morbidity and 
mortality in Zimbabwe contrary to the traditionally 
reported similar tumours.78 It is not clear whether the 
cause o f these deaths in Zimbabwe is due to the 
malignancy alone or patients secumbing to the HIV / 
AIDS and its associated co-infections.
With the advent o f highly active antiretroviral therapy 
(HAART), HIV / AIDS is now a treatable but chronic
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disease and patients live longer once effective 
treatment has been established for each individual.9 
The effect o f HAART on HIV related malignancies like 
OSSN has not yet been studied. However, anecdotal 
evidence suggest that in patients who. develop the 
malignancy prior to commencing treatment HAART 
does not interrupt tumour growth or even its 
recurrence.
There is very little published information on bilateral 
OSSN the world over today. Four patients with bilateral 
OSSN are being reported to illustrate that OSSN is 
potentially a bilateral condition and to encourage 
authors to be explicit on laterality when reporting eye 
problems. This report will alert practitioners o f a 
possible increase in bilateral HTV related OSSN since 
HIV / AIDS has been transformed by HAART from 
being a very fatal disease to a chronic one.
Clinical records.
The table below summarises some important features 
o f the four patients with bilateral OSSN who were 
attended to at Sekuru Kaguvi Hospital Eye Unit, 
Parirenyatwa Group o f Hospitals in Zimbabwe 
between 2007 and 2010.
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Table I: Case summaries.
CASE DIAGNOSIS RISK FACTORS MANAGEMENT OUTCOME
1. 63 year old male who first 1. Left invasive squamous cell 1. HIV positive, 
presented in July 2007 with left carcinoma of conjunctiva. 2. CD4 cell count was 150.
conjunctival growth for six 2. Right eye was normal and 3. Peasant farmer,
months. did not have signs of OSSN. post exenteration to left
1. Enucleation of left eye. 1. Left socket healed well
2. Patient started on HAART. within three months
3. Radiotherapy was given time
Orbit.
2. 27 year old male who first 
presented in Sept 2007 with 
right conjunctival growth 
for eight months.
1. Right invasive squamous 
cell carcinoma of 
conjunctiva.
2. Left eye was normal and 
did not have signs of OSSN.
1. HIV positive.
2. CD4 cell count was 200.
1. Enclueation of right eye.
2. Patient started on 
HAART.
1. Right socket healed well
1. Right socket healed well 
within four months 
time.
2. One and half years later 
patient presented with 
advanced OSSN left 
orbit.
3. 32 year old female who first 
presented in April 2008 with left 
conjunctival growth.
1. Left invasive squamous 
cell carcinoma of 
conjunctiva.
2. Right eye was free of 
tumour.
1. HIV positive.
2. CD4 cell count was 175.
1. Enucleation of right eye
2. Patient was started on
HAART.
1. Left socket healed well 
within four months time.
2. One year later patient 
presented with advanced 
right OSSN.
4. 30 year old female who first 
presented in May 2008 with 
bilateral conjunctival growths.
1. Right invasive squamous 
cell carcinoma of 
conjuctiva
2. Left carcinoma in situ.
1. HIV positive.
2. CDS cell count was 150.
1. Enucleation of right eye.
2. Excision of conjunctival 
growth left eye
3. Patient started on HAART.
1. Right socket healed well 
within three months time
2. Left eye no tumour 
recurrence as yet.
All the patients were black indigenous Zimbabweans, 
who did not smoke. They had no history of allergic eye 
problems. They all were heterosexual with multiple 
partners. The last patient lived in an urban setting while 
the others came from rural settings. Patients two and 
four were self-employed as informal traders, while the 
other two were peasant farmers. None o f the patients 
had instilled traditional eye medicines in their eyes.
None o f the patients had been tested for HIV when 
they presented to us initially. Extended enucleations 
had to be performed in all patients because the tumours 
were extensively involving the globes but had not 
spread into the orbits or beyond.
Histologically all four neoplasms showed figures of 
epithelial cells with focal keratinisation in keeping with 
squamous cell carcinomas. All the tumours were 
classical epidermoid carcinomas with no evidence of 
mucoid differentiation.
Although efforts had been made to commence all 
patients on HAART prior to their discharge from 
hospital, monitoring compliance to HAART was left to 
the local opportunistic infections clinics. Our contact 
with the last patient has been regular since she is living 
in Harare. The other three patients came from districts 
out o f Harare and regular follow-up was technically 
difficult for patients to comply with because of 
transport costs.
All patients were alive and doing well with no clinical 
evidence of recurrent disease three months post 
surgery. Three patients who had presented with uni­
ocular disease were lost to quarterly follow-up visits
and only returned with advanced OSSN affecting the 
second eye approximately two years after removal of 
the first eye. Reasons given for defaulting follow-up 
were financial in all three. Fear o f loosing the only eye 
was given as the reason for delaying coming back 
despite the counseling sessions received before the 
initial discharge from the ward and knowledge of their 
conditions. The three patients underwent orbital 
exenteration with the hope o f clearing the tumours. 
Unfortunately this was not feasible since the tumours 
had eroded the orbital walls in all three patients and 
they all demised within three to six months o f orbital 
exenteration surgery.
Figure 1: Patient 1 three weeks post exenteration.
The fourth patient had presented with bilateral disease. 
The eye with advanced disease involving the globe was
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enucleated while the other lesion was completely 
excised. This patient has managed to maintain regular 
follow up with us and there is no clinical evidence o f 
tumour recurrence in the socket and on the remaining 
eye. The patient continues to take HAART without fail 
and her general well being is impressive although she 
has to battle with the cosmetic problem o f having lost 
one eye.
Discussion
The aetiology of OSSN is a subject of much debate and 
a lot still has to be done in terms of research to establish 
the cause of this disease.10’11 Its association with HIV 
in fection  in some regions o f  the w orld  is 
unquestionable.12'14 Traditionally accepted risk factors 
for OSSN include advanced age, male gender, 
exposure to solar ultraviolet light, cigarette smoking 
and human papilloma virus infection.15'17 Clinico- 
pathological diagnosis o f OSSN has largely been based 
on histological reports o f surgically excised tumour 
tissue while the standard treatment was surgical 
excision o f tumour plus or minus cryotherapy. 
However of late, clinicians are moving towards less 
invasive investigative and treatment modalities for 
these cancers, hence the increasing use of impression 
cytology and the use o f chemotherapeutic agents like 
mitomycin C, 5-flourouracil and interferon alpha 2b 
respectively.1819
Increasing incidence o f OSSN, emergency o f OSSN 
epidemics in countries where the tumour had not been 
previously reported on before, lack o f gender 
predilection, increased mortality and morbidity rates 
associated with OSSN and the identification of new 
risk factors like HIV infection have been much 
publicized during the last decade although very little 
has been reported on regarding bilateral cases o f OSSN 
worldwide.2021
Gerick et al reported on a patient with atopic 
dermatitis who presented to them with bilateral 
OSSN22, while Grueb and colleagues reported on a 75 
year old patient who presented with bilateral OSSN 
following 30 years o f chronic exposure to wood dust23. 
Lam and colleagues reported on two bilateral cases of 
conjunctival epidermoid carcinoma which is a rare 
familial type tumour seen among teenagers.24
The emergence o f bilateral cases o f OSSN the world 
over is a cause o f concern for two reasons: whether the 
currently reported rates o f OSSN refer to patients or 
eyes and whether increased longevity o f HIV / AIDS 
patients with uni-ocular OSSN may be associated with 
increased likelihood o f developing OSSN in the 
previously unaffected eyes.
Many publications on ocular diseases do not make a 
distinction on whether the quoted frequency rates o f a 
condition refer to affected patients or eyes. Under 
normal circumstances patients have two eyes and 
disease severity is graded differently when one has 
bilateral disease as opposed to unilateral disease. 
Treatment options for each eye may be tailored
according to laterality, location and severity o f disease 
as has been the experience with retinoblastomas and 
choroidal melanomas.25'26
Three (75%) o f our patients expressed fear o f loosing 
the second eye contributed to delayed presentation. 
This should alert practitioners to look out for such cases 
and counsel patients reminding them o f the importance 
o f regular follow up and early presentation to the 
ophthalmologists once they notice symptoms o f the 
disease.
The increased longevity o f HIV / AIDS patients on 
HAART has been one o f the greatest medical 
achievements World wide to date. The effect o f 
HAART on OSSN growth and recurrence has not been 
studied. Experience gained on these four cases on the 
effect o f HAART on OSSN is not conclusive since our 
center could not monitor these patients closely. It is our 
hope that the universal access to HAART being 
advocated for today is an achievable goal and HAART 
may be looked at as a tool to prevent HIV transmission 
and occurrence o f HIV related malignancies.9
Conclusion
HIV related OSSN has a high potential o f becoming 
bilateral disease. Clinicians should be on the look out 
for this in view of the drive towards universal access to 
HAART being advocated for to date.
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